No false modesty here – we are good at what we do! Although we are a young clinical research entity, we have produced high quality data, and over enrolled our past and ongoing studies. Our high numbers of subjects have resulted in multiple sponsor audits without any significant findings. We were also one of three sites (from a total of 162 US sites) for a pivotal Phase III study selected for FDA audit, and there were no significant findings from the 5 day audit of our facility and data. Initial success has been wonderful, but we avoid complacency by continually seeking to get even better!